France Smartcare Market Size and Forecasts (2020-2030)
France Smartcare Market Size and Forecasts (2020 – 2030), Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Connected Beds, Remote Patient Monitoring Systems, Smart Pills, Smart Syringes, RFID Systems, Electronic Health Records, and Others) and End User (Hospitals and Clinics, Medical Nursing Homes, Home Healthcare, and Others)
$2,415 – $3,885
- Description
- Toplines
- Reasons for Buying
- Table of Contents
- List of Tables
- LIst of Figures
- List of Companies
- Reviews (0)
Description
Favourable reimbursement scenarios
Telehealth bridges the gap between patients, and physicians and health systems by enabling patients to communicate with physicians through virtual channels remotely. It helps reduce unnecessary visits to hospitals for minor issues. When paired with telehealth services, wearable technology can help care providers study real-time patient data to generate intelligent individualized insights and curate the best treatment plan from the comfort and safety of their homes. Due to the COVID-19 outbreak, there is an increase in the use of telehealth services and wearable technologies that are tagged through medical device connectivity. After the outbreak, virtual consultations are fully reimbursed by the French Social Security. Remote patient monitoring (RPM) is a telehealth program that collects and analyzes patient health or medical data. It has expanded in the past decade and has improved medical outcomes and treatment of noncommunicable chronic diseases. However, implementation of RPM into routine clinical activities has been limited. The Ministry of Health in France introduced a temporary funding program named as ETAPES in 2014. Through this program, healthcare providers and RPM solution providers for diabetes, chronic heart failure, chronic renal failure, chronic respiratory failure, and therapeutic implantable cardiac prosthesis are temporarily being funded. Moreover, the program is a prefiguration for integrating the RPM funding model for routine clinical activities into a model. It was extended till 2022 to encourage the use of innovative technologies in addition to exploring the advantages telemedicine could bring to the French health system. The growing focus of French Government on reimbursement for telehealth and RPM creates awareness about the use of smartcare devices in the healthcare system. Thus, the availability of favorable reimbursement scenario fuels the growth of the France smartcare market.
The shift of point of care (PoC) from hospital to home provides good chances for better, consistent, and timely interaction between patient and doctor, making cloud and mobility-driven medical devices a foremost trend. Also, the COVID-19 outbreak crisis triggered the importance of AI in healthcare, which led to the growing emphasis on home-based care due to limited hospital bed capacity and a scarcity of skilled healthcare professionals. By monitoring the patient’s vitals remotely, healthcare professionals can avoid hospital admissions if patients can be treated virtually. As a result, hospitals can reserve beds only for patients requiring critical care. Home monitoring, often known as remote patient monitoring (RPM), has a subset of applications that have different requirements and frequency of data delivery, including monitoring chronic diseases and tracking patients’ health status.
Home healthcare provides great prospects for smartcare. Solutions to inefficient, costly, and single-use devices for remote patient care can be provided through connected medical devices that utilize the cloud, Machine-to-Machine (M2M) connectivity, and cellular networks. Connected devices help transfer data to caregivers or clinicians, allowing proactive care delivery. Connectivity in the medical industry improves the quality and efficiency of patient treatments.
The rising numbers of connected medical devices and increasing improvements in the systems and software that support the capture and transmission of medical-grade data and connectivity technologies and services have given rise to the Internet of Medical Things (IoMT). Through IoMT, the connectivity between sensors and devices is expected to aid in real-time patient care, even remotely, thereby improving communication within and between medical facilities. Owing to the aforementioned factors, the market for smartcare is expected to proliferate during the forecast period.
France has long been recognized for its excellence in healthcare, with renowned medical institutions, cutting-edge research, and highly skilled healthcare professionals. According to the World Health Organization (WHO), France ranks sixth globally in terms of investments (public and private) in healthcare. The government of France is focusing on introducing technologically advanced products in its healthcare facilities to become a global healthcare innovation leader in the future. The Health Innovation 2030 plan was launched by the government of France in 2021. As a part of this plan, the government invested US$ 693.46 million (€ 650 million) to accelerate the digital health strategy in the country. Thus, the increasing focus of government on digital health initiatives drives the smartcare market growth in France.
Rising product launches of smart wearable devices that can be used for health monitoring by the population and growing use of telehealth and telemedicine applications for consultations boost the growth of the France smartcare market. Furthermore, increasing use of EHR and RPM technologies by healthcare institutions such as hospitals, nursing homes, and clinics for monitoring and managing their patient flow to improve the quality of care and working efficiency of the institution in France also bolsters the market growth.
According to an article published by Business News Daily, an average hospital room contains 15–20 connected medical devices. In a few hospitals, connected medical devices outnumber mobile devices, such as laptops and smartphones, by four to one. Nearly 85,000 connected devices are housed in a large hospital, with each device performing significant roles in delivering care while ensuring operational efficiency. These connected devices are vulnerable to malicious cyberattacks. Therefore, the number of data breaches associated with healthcare information and patient data has been gradually increasing. Healthcare is second only to the finance industry in the number of cyberattacks annually. Recent cyberattacks have shifted the issue of cybersecurity and data risk management centers in front. In December 2022, a hospital in Versailles canceled operations and had to transfer some patients to other hospitals for emergency surgeries due to a cyberattack. Similarly, in August 2022, the Corbeil-Essonnes hospital was also targeted by a cyberattack. Thus, digital healthcare is a lucrative target for cyberattacks and data breaches, with misconfigured cloud storage buckets, weaponized ransomware, and phishing e-mails, which, in turn, restrains the adoption of smartcare.
Type-Based Insights
The smartcare market, by product type, is segmented into connected beds, remote patient monitoring, smart pills, smart syringes, RFID systems, electronic health records, and others. The remote patient monitoring segment held a largest market share in 2022, while electronic health records segment is anticipated to register a highest CAGR of 16.0% during the forecast period.
End User-Based Insights
The smartcare market, by end user, is segmented into hospitals and clinics, medical nursing homes, home healthcare, and others. The hospitals and clinics segment held a largest market share in 2022, while home healthcare segment is anticipated to register a highest CAGR of 15.8% during the forecast period.
A few of the major primary and secondary sources referred to while preparing the report on the France smartcare market are the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), and National Digital Health Agency (ANS).
.
Summary Info
Industry: | |
---|---|
Pricing options: | |
Geographical coverage: | |
Year of Publication: |
According to our new research study on “France Smartcare Market Forecast To 2030 – Country Analysis- by Type and End User,” the France smartcare market size is expected to grow from US$ 3.728 billion in 2022 to 11.475 billion by 2030; it is estimated to register a CAGR of 15.1% during the forecast period. The report highlights the key factors driving the France smartcare market growth and prominent players with their developments in the market.
Smartcare is the embodiment of smart systems to improve patient flow and patient care in healthcare institutions through intelligent interchange of data. In smartcare, the patient data is immediately forwarded from one department to another or from one facility to another, depending on where the patient is scheduled to go next. Remote patient monitoring (RPM), electronic health record (EHR), and radiofrequency identification (RFID) systems used in healthcare settings are among the technologies used in smartcare.
The smartcare market, by product type, is segmented into connected beds, remote patient monitoring, smart pills, smart syringes, RFID systems, electronic health records, and others. The remote patient monitoring segment held a largest market share in 2022, while electronic health records segment is anticipated to register a highest CAGR of 16.0% during the forecast period. Remote Patient Monitoring (RPM) technology is used to collect patient’s medical information from health monitoring and diagnostic devices from patient’s location and then transfer it to the physician or doctor at another location. RPM remotely supervises and analyzes physiological parameters such as pulse rate, heart rate, blood oxygen levels, blood sugar, blood pressure, and vital signs. This helps reduce the patient hospitalization time and reduces hospital visits, which further improves patient’s care and quality of life. Remote Monitoring devices development puts the future balance of public finances, especially healthcare, in jeopardy. TELEHPAD is an initiative that aims to make healthcare more accessible in rural regions. Patients, including both nursing home residents and the general local population, access teleconsultations as rooms in the nursing homes are directly connected to general and psychiatric hospitals. Thus, they can benefit from teleconsultations in geriatric medicine, psychiatry, dermatology, cardiology, and neurology. TELEFIGAR is another program aimed at offering nursing home residents the option of teleconsultations with experts in geriatrics, neurology, dermatology, and endocrinology. Electronic Health Records (EHRs) or Electric Medical Records (EMRs) are patient-centered and real-time digital records that enable patient data to be readily available to authorized healthcare professionals. It contains patient’s medical history, medications, allergies, treatment plans, diagnoses, immunization dates, radiology images, and laboratory test results. The national digital health agency (ANS) was formed in December 2019 to operationalize the government’s e-health strategy. Dossier Medical Partagé (DMP) is a fully interoperable EMR for all French citizens who are covered by health insurance. The nationwide DMP was launched in 2019. It is a free, secure, and confidential health record that stores patient’s information in one centralized, digital location. Increasing initiatives by French Government to introduce EHRs in their healthcare system boost the France smartcare market growth for the electronic health records segment.
The smartcare market, by end user, is segmented into hospitals and clinics, medical nursing homes, home healthcare, and others. The hospitals and clinics segment held a largest market share in 2022, while home healthcare segment is anticipated to register a highest CAGR of 15.8% during the forecast period. Hospitals are the fastest-growing end users of the smartcare market in France. Hospitals are complex organizations that provide healthcare services such as disease screening, diagnosis, and treatment with the help of modernized equipment. Hospitals and clinics are the primary healthcare centers patients seek for their first aid and treatment. The implementation of advanced diagnostics technologies in hospitals has paved the way for improved and early detection of disease. It also supported research related to disease treatment. Hospitals in France are investing in introducing technologically advanced smartcare devices in their organizations to maintain the proper flow of treatment. The rising focus of clinics on installing RPM and EHR devices and software to gain easy access to data and monitor patients from clinics rather than increasing the visits of patients and admitting them to hospital in case of emergency also fuels the France smartcare market growth for the hospitals and clinics segment. The shift of patient care from hospitals to homes is significant. Many patients prefer the comfort of at-home health monitoring over costly and inconvenient hospital care. Sensor embedded systems enable the monitoring of vital signs such as pulse, pH, temperature, and others in the comfort of a patient’s home. Devices that integrate sensors and electronics can operate at low power levels are rising. As a result, numerous applications of sensors in the pharmaceutical industry are becoming more valuable. During reflections on the COVID-19 crisis, patients of one archetype, focused on convenience, are beginning to experiment with new, digital-first pharmacy entrants that provide in-home pharmacy experiences. Multi-disease patients seek higher-touch clinical support models in the home and digitally, as well as guidance from a trusted pharmacist in managing several medications. Thus, a growing demand for home healthcare has sparked interest France smartcare market.
Oracle Corp, Samsung Healthcare, BodyCap, GE Healthcare Technologies, Orme SARL, AdolfWurth GmbH & Co KG, McKesson Corp, Kaspard, Domalys SAS, Siemens Healthineers, MintT, and Groupe WINNCARE SAS are a few of the key companies operating in the France smartcare market.
Companies operating in the France smartcare market adopt various organic and inorganic strategies. Organic strategies mainly include product launches and product approvals. Acquisitions, collaborations, and partnerships are among the inorganic growth strategies witnessed in the France smartcare market. These growth strategies allow the market players to expand their businesses and enhance their geographic presence, thereby contributing to the overall microbial identification methods market growth. Further, acquisition and partnership strategies help them strengthen their customer base and expand their product portfolios.
o Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the smartcare market.
o Highlights key business priorities in order to assist companies to realign their business strategies.
o The key findings and recommendations highlight crucial progressive industry trends in the France smartcare market, thereby allowing players across the value chain to develop effective long-term strategies.
o Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
o Scrutinize in-depth France market trends and outlook coupled with the factors driving the market, as well as those hindering it.
o Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing, and distribution.
TABLE OF CONTENTS
1. Introduction
1.1 The Research Team Report Guidance
1.2 Market Segmentation
2. Research Methodology
2.1 Coverage
2.2 Secondary Research
2.3 Primary Research
3. France Smartcare Market – Market Landscape
3.1 Overview
3.1.1 France PEST Analysis
4. France Smartcare Market – Key Market Dynamics
4.1 Market Drivers
4.1.1 Growing Penetration of EHR or EMR and Medical Device Connectivity
4.1.2 Favourable Reimbursement Scenario
4.2 Market Restraints
4.2.1 High Risk of Cyberattack
4.3 Market Opportunities
4.3.1 Promising 5G Technology to Enhance Smartcare
4.4 Future Trends
4.4.1 Inclination Toward Home Healthcare
4.5 Impact Analysis
5. France Smartcare Market – Country Analysis
5.1 France Smartcare Market Revenue Forecast and Analysis
6. France Smartcare Market – Revenue and Forecast to 2030 – by Product Type
6.1 Overview
6.2 France Smartcare Market Revenue Share, by Product Type 2022 & 2030 (%)
6.3 Remote Patient Monitoring Systems
6.3.1 Overview
6.3.2 Remote Patient Monitoring Systems: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Electronic Health Records
6.4.1 Overview
6.4.2 Electronic Health Records: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
6.5 RFID Systems
6.5.1 Overview
6.5.2 RFID Systems: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
6.6 Smart Syringes
6.6.1 Overview
6.6.2 Smart Syringes: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
6.7 Connected Beds
6.7.1 Overview
6.7.2 Connected Beds: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
6.8 Smart Pills
6.8.1 Overview
6.8.2 Smart Pills: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
6.9 Others
6.9.1 Overview
6.9.2 Others: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
7. France Smartcare Market – Revenue and Forecast to 2030 – by End User
7.1 Overview
7.2 France Smartcare Market Revenue Share, by End User 2022 & 2030 (%)
7.3 Hospitals and Clinics
7.3.1 Overview
7.3.2 Hospitals and Clinics: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Medical Nursing Homes
7.4.1 Overview
7.4.2 Medical Nursing Homes: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
7.5 Home Healthcare
7.5.1 Overview
7.5.2 Home Healthcare: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
8. Company Profiles
8.1 Oracle Corp
8.1.1 Key Facts
8.1.2 Business Description
8.1.3 Products and Services
8.1.4 Financial Overview
8.1.5 SWOT Analysis
8.1.6 Key Developments
8.2 GE HealthCare Technologies Inc
8.2.1 Key Facts
8.2.2 Business Description
8.2.3 Products and Services
8.2.4 Financial Overview
8.2.5 SWOT Analysis
8.2.6 Key Developments
8.3 McKesson Corp
8.3.1 Key Facts
8.3.2 Business Description
8.3.3 Products and Services
8.3.4 Financial Overview
8.3.5 SWOT Analysis
8.3.6 Key Developments
8.4 Siemens Healthineers AG
8.4.1 Key Facts
8.4.2 Business Description
8.4.3 Products and Services
8.4.4 Financial Overview
8.4.5 SWOT Analysis
8.4.6 Key Developments
8.5 Samsung Healthcare
8.5.1 Key Facts
8.5.2 Business Description
8.5.3 Products and Services
8.5.4 Financial Overview
8.5.5 SWOT Analysis
8.5.6 Key Developments
8.6 Orme SARL
8.6.1 Key Facts
8.6.2 Business Description
8.6.3 Products and Services
8.6.4 Financial Overview
8.6.5 SWOT Analysis
8.6.6 Key Developments
8.7 Kaspard
8.7.1 Key Facts
8.7.2 Business Description
8.7.3 Products and Services
8.7.4 Financial Overview
8.7.5 SWOT Analysis
8.7.6 Key Developments
8.8 MintT
8.8.1 Key Facts
8.8.2 Business Description
8.8.3 Products and Services
8.8.4 Financial Overview
8.8.5 SWOT Analysis
8.8.6 Key Developments
8.9 BodyCap
8.9.1 Key Facts
8.9.2 Business Description
8.9.3 Products and Services
8.9.4 Financial Overview
8.9.5 SWOT Analysis
8.9.6 Key Developments
8.10 Adolf Wurth GmbH & Co KG
8.10.1 Key Facts
8.10.2 Business Description
8.10.3 Products and Services
8.10.4 Financial Overview
8.10.5 SWOT Analysis
8.10.6 Key Developments
8.11 Domalys SAS
8.11.1 Key Facts
8.11.2 Business Description
8.11.3 Products and Services
8.11.4 Financial Overview
8.11.5 SWOT Analysis
8.11.6 Key Developments
8.12 Groupe WINNCARE SAS
8.12.1 Key Facts
8.12.2 Business Description
8.12.3 Products and Services
8.12.4 Financial Overview
8.12.5 SWOT Analysis
8.12.6 Key Developments
9. Appendix
9.1 About Research Team
9.2 Glossary of Terms
LIST OF TABLES
Table 1. Glossary of Terms
LIST OF FIGURES
Figure 1. France Smartcare Market Segmentation
Figure 2. France Smartcare Market – Key Takeaways
Figure 3. France: PEST Analysis
Figure 4. France Smartcare Market: Key Industry Dynamics
Figure 5. France Smartcare Market Impact Analysis of Drivers and Restraints
Figure 6. France Smartcare Market – Revenue Forecast and Analysis – 2020–2030
Figure 7. France Smartcare Market Revenue Share, by Product Type 2022 & 2030 (%)
Figure 8. Remote Patient Monitoring Systems: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
Figure 9. Electronic Health Records: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. RFID Systems: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Smart Syringes: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Connected Beds: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
Figure 13. Smart Pills: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Others: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. France Smartcare Market Revenue Share, by End User 2022 & 2030 (%)
Figure 16. Hospitals and Clinics: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Medical Nursing Homes: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Home Healthcare: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
Figure 19. Others: France Smartcare Market – Revenue and Forecast to 2030 (US$ Million)
The List of Companies – France Smartcare Market
o Oracle Corp
o Samsung Healthcare
o BodyCap
o GE Healthcare Technologies
o Orme SARL
o AdolfWurth GmbH & Co KG
o McKesson Corp
o Kaspard
o Domalys SAS
o Siemens Healthineers
o MintT
o Groupe WINNCARE SAS
You must be logged in to post a review.
Reviews
There are no reviews yet.